314
T.E. 1 Métodos de estudio de la inflamación de la vía aérea: LBA y esputo inducido
24. Cruz MJ, Sánchez-Vidaurre S, Romero
PV, Morell F, Muñoz X. Impact of age on
pH, 8-isoprostane, and nitrogen oxides
in exhaled breath condensate. Chest.
2009;135:462-7.
25. Zietkowski Z, Skiepko R, Tomasiak-Lozo-
wska MM, Bodzenta-Lukaszyk A. Anti-IgE
therapy with omalizumab decreases en-
dothelin-1 in exhaled breath condensate
of patients with severe persistent allergic
asthma. Respiration. 2011;80:534-42.
26. Zietkowski Z, Skiepko R,Tomasiak-Lozows-
ka MM, Bodzenta-Lukaszyk A. Airway in-
flammation and eotaxin in exhaled breath
condensate of patients with severe persis-
tent allergic asthma during omalizumab
therapy. Adv Med Sci. 2011;56:318-22.
27. Adamko DJ, Sykes BD, Rowe BH. The me-
tabolomics of asthma: novel diagnostic
potential. Chest. 2012;141:1295-302.
28. Carraro S, Giordano G, Reniero F, Carpi
D, Stocchero M, Sterk PJ, et al. Asthma
severity in childhood and metabolomic
profiling of breath condensate. Allergy.
2013;68:110-7.
29. Ono E, Mita H, Taniguchi M, Higashi N,
Tsuburai T, Hasegawa M, et al. Increase
in inflammatory mediator concentrations
in exhaled breath condensate after aller-
gen inhalation. J Allergy Clin Immunol.
2008;122:768-73.
30. Prieto L, Palacios R, Aldana D, Ferrer A, Per-
ez-Frances C, Lopez V, et al. Effect of aller-
gen-specific immunotherapy with purified
Alt a1 on AMP responsiveness, exhaled ni-
tric oxide and exhaled breath condensate
pH: a randomized double blind study. Al-
lergy Asthma Clin Immunol. 2010;6:27.
31. Scichilone N, Minaldi C, Santagata R, Batta-
glia S, Camarda G, BelliaV. Anti-inflamma-
tory effects of pre-seasonal Th1-adjuvant
vaccine to Parietaria judaica in asthmatics.
J Asthma Allergy. 2011;4:19-25.
32. Thomson NC, Patel M, Smith AD. Lebriki-
zumab in the personalized management
of asthma. Biologics. 2012;6:329-35.
montelukast. Am J Respir Crit Care Med.
1999;160:1227-31.
16. Silkoff PE, Wakita S, Chatkin J, Ansarin K,
Gutierrez C, Caramori M, et al. Exhaled
nitric oxide after beta2-agonist inhalation
and spirometry in asthma. Am J Respir
Crit Care Med. 1999;159:940-4.
17. Beck-Ripp J, Griese M, Arenz S, Koring
C, Pasqualoni B, Bufler P. Changes of ex-
haled nitric oxide during steroid treat-
ment of childhood asthma. Eur Respir J.
2002;19:1015–19.
18. Petsky HL, Cates CJ, Lasserson TJ, Li AM,
Turner C, Kynaston JA, et al. A systematic
review and meta-analysis: tailoring asth-
ma treatment on eosinophilic markers (ex-
haled nitric oxide or sputum eosinophils).
Thorax. 2012;67:199-208.
19. Pérez de Llano LA. Nitric Oxide (NO) in
managing asthma. Arch Bronconeumol.
2012;48:35-6.
20. Caballero S. Análisis de las concentra-
ciones de Leucotrienos-B4 y 8-isoprosta-
no en el condensado exhalado con la re-
spiración para el estudio de la inflamación
bronquial en el asma bronquial.Tesis Doc-
toral Universidad de Valencia. Departa-
ment de Pediatria, obstetricia i Ginecolo-
gia. 2011.
21. Thomas PS, Lowe AJ, Samarasinghe P,
Lodge CJ, Huang Y, Abramson MJ, et al.
Exhaled breath condensate in pediatric
asthma: Promising new advance or pour-
ing cold water on a lot of hot air? A sys-
tematic review. Pediatr Pulmonol. 2013
doi: 10.1002/ppul.22776.
22. Ahmadzai H, Huang S, Hettiarachchi R, Lin
JL, Thomas PS, Zhang Q. Exhaled breath
condensate: a comprehensive update. Clin
Chem Lab Med. 2013;18:1-19.
23. Hoffmeyer F, Raulf-Heimsoth M, Harth V,
Bünger J, Brüning T. Comparative analy-
sis of selected exhaled breath biomark-
ers obtained with two different tempera-
ture-controlled devices. BMC Pulm Med.
2009;9:48.
